Gastroparesis Drugs Market Revenue 2024 to 2034
Gastroparesis Drugs Market Revenue 2024 to 2034
The Gastroparesis Drugs Market is projected to grow from USD 28.53 Bn in 2024 to USD 145.38 Bn by 2034, at a CAGR of 17.7%. Growth is driven by rising prevalence of gastrointestinal disorders, advances in prokinetic and antiemetic therapies, and increasing demand for effective treatments to improve patient quality of life.
Report ID: 10383
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 28.53 Bn
Forecast Year,
USD 145.38 Bn
CAGR, 2025 -
17.68%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Gastroparesis Drugs Market Size Analysis
Gastroparesis Drugs Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 9.13 | 10.71 | 12.50 | 14.70 | 17.19 | 20.21 | 23.81 | 27.92 | 32.84 | 38.70 | 45.66 |
| Biologics | 9.70 | 11.41 | 13.52 | 15.99 | 18.92 | 22.26 | 26.16 | 30.78 | 36.18 | 42.27 | 49.74 |
| Advanced Therapies | 5.14 | 6.08 | 7.17 | 8.38 | 9.85 | 11.61 | 13.68 | 16.23 | 19.13 | 22.67 | 26.60 |
| Others | 4.56 | 5.37 | 6.32 | 7.43 | 8.77 | 10.32 | 12.14 | 14.27 | 16.81 | 19.88 | 23.38 |
Gastroparesis Drugs Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 10.27 | 12.09 | 14.18 | 16.65 | 19.48 | 22.91 | 26.96 | 31.70 | 37.23 | 43.98 | 51.66 |
| Cardio-Metabolic | 5.14 | 6.06 | 7.14 | 8.41 | 9.91 | 11.64 | 13.65 | 16.15 | 18.99 | 22.25 | 26.11 |
| Infectious | 4.56 | 5.36 | 6.29 | 7.39 | 8.74 | 10.29 | 12.09 | 14.18 | 16.85 | 19.86 | 23.27 |
| CNS | 3.99 | 4.72 | 5.58 | 6.56 | 7.74 | 9.10 | 10.74 | 12.58 | 14.74 | 17.27 | 20.44 |
| Others | 4.56 | 5.34 | 6.32 | 7.48 | 8.85 | 10.45 | 12.35 | 14.58 | 17.14 | 20.16 | 23.89 |
Gastroparesis Drugs Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 12.55 | 14.74 | 17.34 | 20.39 | 23.95 | 28.16 | 33.11 | 38.94 | 45.71 | 53.83 | 63.39 |
| Retail Pharmacy | 10.27 | 12.08 | 14.20 | 16.72 | 19.67 | 23.21 | 27.39 | 32.34 | 38.20 | 44.97 | 53.14 |
| Online/Other | 5.71 | 6.75 | 7.97 | 9.40 | 11.10 | 13.03 | 15.29 | 17.91 | 21.05 | 24.73 | 28.84 |
Gastroparesis Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 11.41 | 13.40 | 15.72 | 18.36 | 21.59 | 25.34 | 29.89 | 35.29 | 41.50 | 48.97 | 57.46 |
| Europe | 7.99 | 9.40 | 11.11 | 13.13 | 15.48 | 18.26 | 21.40 | 25.00 | 29.66 | 34.97 | 41.10 |
| Asia Pacific | 6.85 | 8.09 | 9.52 | 11.28 | 13.27 | 15.65 | 18.42 | 21.77 | 25.43 | 29.77 | 35.27 |
| Latin America | 1.14 | 1.35 | 1.58 | 1.85 | 2.18 | 2.58 | 3.05 | 3.56 | 4.20 | 4.94 | 5.82 |
| Middle East & Africa | 1.14 | 1.35 | 1.59 | 1.88 | 2.20 | 2.58 | 3.03 | 3.56 | 4.18 | 4.88 | 5.73 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
